Geron Corporation (NASDAQ:GERN) saw an upside of 2.51% to close Monday at $3.27 after adding $0.08 on the day. The 5-day average trading volume is 6,073,880 shares of the company’s common stock. It has gained $3.35 in the past week and touched a new high 2 times within the past 5 days. An average of 17,241,496 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 9,303,752.
GERN’s 1-month performance is 60.29% or $1.18 on its low of $2.02 reached on 12/27/22. The company’s shares have touched a 52-week low of $0.99 and high of $3.84, with the stock’s rally to the 52-week high happening on 01/04/23. YTD, GERN has achieved 35.12% or $0.85 and has reached a new high 2 times. However, the current price is down -14.84% from the 52-week high price.
GERN stock has a beta of 0.69. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 799.84 while the price-to-book (PB) in the most recent quarter is 12.11.
Geron Corporation’s quick ratio for the period ended September 29 was 2.70, with the current ratio over the same period at 2.70. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.35, while the total debt to equity was 0.47. The firm’s gross profit as reported stood at $115.39 million against revenue of $1.39 million.
For the quarterly period ending September 29 this year, Geron Corporation’s cash and short-term investments amounted to $133.68 million against total debt of $55.5 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 34.96% to -$41.05 million, while revenue of -$28.12 million was 31.5% off the previous quarter. Analysts expected GERN to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.1, representing a -11.10% surprise. EBITDA for the quarter stood at more than -$39.64 million. GERN stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 124.43 million, with total debt at $55.5 million. Shareholders hold equity totaling $381.24 million.
Let’s look briefly at Geron Corporation (GERN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 66.65% to suggest the stock is trending Neutral, with historical volatility in this time period at 64.03%.
The stock’s 5-day moving average is $3.16, reflecting a +3.48% or $0.11 change from its current price. GERN is currently trading +57.21% above its 20-day SMA, +40.95% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +50.69% and SMA200 by+109.62%.
Stochastic %K and %D was 60.65% and 60.27% and the average true range (ATR) pointed at 0.27. The RSI (14) points at 65.08%, while the 14-day stochastic is at 62.00% with the period’s ATR at 0.26. The stock’s 9-day MACD Oscillator is pointing at -0.02 and 0.15 on the 14-day charts.
In the most recent analyst report for Geron Corporation (NASDAQ: GERN), Wedbush launched coverage with an Outperform rating. Analysts offering their rating for GERN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate GERN as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 5 have offered a “buy” rating.
What is GERN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.00 and a high of $7.00, with their median price target at $5.00. Looking at these predictions, the average price target given by analysts is for Geron Corporation (GERN) stock is $5.33.